| Arthur George D'souza, MD | |
|
249 Danbury Rd, Wilton, CT 06897 | |
| (203) 762-3353 | |
| (203) 761-8563 |
| Full Name | Arthur George D'souza |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 58 Years |
| Location | 249 Danbury Rd, Wilton, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306937602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 015934 (Connecticut) | Secondary |
| 207R00000X | Internal Medicine | 015934 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Norwalk Hospital | Norwalk, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
Federal officials gave negative assessments to more than 25 percent of these prescription drug plans. In the Washington area, that number is even higher. Also in the news, Medicare's database comparing hospital patient safety.
Glioblastoma multiforme is an aggressive form of cancer in the brain that is typically fatal. But new findings by VCU Massey Cancer Center and VCU Institute of Molecular Medicine researchers could help increase the effectiveness of the most common current treatments with the addition of lumefantrine, an FDA-approved drug used to treat malaria.
A new poll illustrates the difficulty that cancer patients, survivors and their families face in affording needed health care and paying for other basic necessities such as food and heat, underscoring the need to strongly implement the Affordable Care Act so that it works for people with cancer.
Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.
› Verified 7 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
Federal officials gave negative assessments to more than 25 percent of these prescription drug plans. In the Washington area, that number is even higher. Also in the news, Medicare's database comparing hospital patient safety.
Glioblastoma multiforme is an aggressive form of cancer in the brain that is typically fatal. But new findings by VCU Massey Cancer Center and VCU Institute of Molecular Medicine researchers could help increase the effectiveness of the most common current treatments with the addition of lumefantrine, an FDA-approved drug used to treat malaria.
A new poll illustrates the difficulty that cancer patients, survivors and their families face in affording needed health care and paying for other basic necessities such as food and heat, underscoring the need to strongly implement the Affordable Care Act so that it works for people with cancer.
Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arthur George D'souza, MD 249 Danbury Rd, Wilton, CT 06897-4075 Ph: (203) 762-3353 | Arthur George D'souza, MD 249 Danbury Rd, Wilton, CT 06897 Ph: (203) 762-3353 |
News Archive
Federal officials gave negative assessments to more than 25 percent of these prescription drug plans. In the Washington area, that number is even higher. Also in the news, Medicare's database comparing hospital patient safety.
Glioblastoma multiforme is an aggressive form of cancer in the brain that is typically fatal. But new findings by VCU Massey Cancer Center and VCU Institute of Molecular Medicine researchers could help increase the effectiveness of the most common current treatments with the addition of lumefantrine, an FDA-approved drug used to treat malaria.
A new poll illustrates the difficulty that cancer patients, survivors and their families face in affording needed health care and paying for other basic necessities such as food and heat, underscoring the need to strongly implement the Affordable Care Act so that it works for people with cancer.
Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.
› Verified 7 days ago
Pamela Joy Randolph, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 249 Danbury Road, Wilton, CT 06897 Phone: 203-852-2270 Fax: 203-899-5027 | |
Dr. Craig David Serin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Danbury Rd, Davenport Building, Suite 140, Wilton, CT 06897 Phone: 203-762-3353 Fax: 203-761-8563 | |
Dr. Sarah Kahn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Danbury Rd, Wilton, CT 06897 Phone: 203-276-8490 Fax: 203-276-8491 | |
Dr. Maura L Sparks, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 372 Danbury Rd, Suite 180, Wilton, CT 06897 Phone: 203-276-4015 Fax: 203-834-2639 | |
Varshapriya Iyer, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 436 Danbury Rd, Wilton, CT 06897 Phone: 203-210-7575 Fax: 203-210-7573 | |
Dr. Ahsan Fayyaz Malik, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Old Ridgefield Rd, Wilton, CT 06897 Phone: 203-762-5588 Fax: 203-762-2301 | |
Dr. Karen R Silverberg, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Pipers Hill Rd, Wilton, CT 06897 Phone: 203-762-3507 |